Trials / Sponsors / Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Industry · 11 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Phase I Study of LX22001 for Injection in Healthy Subjects Healthy	Phase 1	2024-08-05
Completed	Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin Healthy	Phase 1	2023-03-23
Completed	Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori Infection	Phase 3	2022-10-30
Completed	Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028	Phase 1	2022-06-30
Completed	Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation Functional Constipation	Phase 3	2022-03-18
Completed	Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer Duodenal Ulcer	Phase 3	2021-10-18
Completed	A Phase I Study of LX-039 Tablets Advanced Breast Cancer	Phase 1	2020-01-07
Completed	A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the E Non-erosive Reflux Disease	Phase 3	2018-10-29
Completed	Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis Erosive Esophagitis (EE)	Phase 3	2018-10-24
Completed	A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, S Healthy	Phase 1	2018-03-19
Unknown	A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors Advanced Breast Cancer	Phase 1	2017-06-12